Kathy, an inventor, is the Founder, CEO, and President of Femasys. She has served as senior executive in the medical technologies industry for nearly three decades and holds over 100 patents globally for Femasys’ products and product candidates. Femasys is focused on developing a suite of in-office technologies that are designed to be safe, natural, and minimally invasive to provide women worldwide with superior reproductive healthcare options — both for permanent birth control and infertility. Since founding Femasys in 2004, Kathy has spearheaded the development of multiple U.S. FDA–regulated products, while taking the company from private to public. Under her leadership, Femasys is focused on advancing two lead clinical stage products while making available commercial assets.